News
Maziar Mike Doustdar appointed as president and chief executive officer of Novo Nordisk
Novo Nordisk today announced that Maziar Mike Doustdar has been appointed as president and chief executive officer, effective 7 August 2025. Mike Doustdar succeeds Lars Fruergaard Jørgensen, who will step down as president and chief executive officer on the same date.
In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed ...
Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...
USANA Health Sciences, Inc., a global leader in cellular nutrition, is proud to announce that Dr. Kathryn Armstrong, Ph.D., will be assuming the role of chief scientific officer at the company ...
Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer - - Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 as ...
Melbourne executive Nathan Smith will take the reins as CEO at NeuroScientific Biopharmaceuticals, bringing his strategic and ...
FDA Commissioner Marty Makary has told staff that Center for Biologics Evaluation and Research Director Vinay Prasad has been given two additional roles: chief medical officer and chief ...
Experienced academic has been Food Standards Agency Chief Scientific Adviser for the last five years and will move to UKHSA ...
Professor Robin May is stepping down after completing a five-year term in the role, and will take up a new position as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback